Autopsy report · NCT03227822

Short Spot Versus Long Lesion Stenting as Best Treatment for Extensive Occlusive SFA Disease

“Unable to include the number of patients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 4 years after it had already started.
• Ran for about 1 year 7 months before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Catharina Ziekenhuis Eindhoven

Sponsor type

University, hospital or other

Conditions

Peripheral Arterial Disease

Interventions

Short spot stenting; Long lesion stenting

Participants

3

Trials that died the same way

• Predictive Factors for Exacerbation Outcome in Severe Refractory Asthmatics
  “Number of included patients is sufficient.” (77% match in meaning)
• Ethibond Suture vs Vessel Loop as Draining Seton for Complex Anal Fistulas
  “Unable to recruit the required number of patients as per the sample size calculated” (75% match in meaning)
• Duration of Postoperative Antibiotic Prophylaxis in Facial Fractures
  “Limited number of patients” (71% match in meaning)
• Pyrexia Management Using an IL-6 Antibody in BRAF+ Melanoma Patients Treated with Dabrafenib/ Trametinib +/- Immunotherapy
  “too few patients could be included” (70% match in meaning)
• Project 4A: Inspiratory Muscle Training and Diaphragm Strength
  “Unable to recruit sufficient number of patients” (69% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.